Type 2 Diabetes Archives - Endocrinology Advisor

NIH Study Compares Four Commonly Used Type 2 Diabetes Medications

By

September 29, 2022

The multicenter, randomized, controlled GRADE study was designed to compare the effectiveness of 4 major FDA-approved medications.

Type 2 Diabetes

Metabolic Surgery Beats Medical, Lifestyle Interventions for Type 2 Diabetes Remission

September 20, 2022

Metabolic or bariatric surgery is more effective and durable than medical and lifestyle interventions for achieving remission of type 2 diabetes.

Obesity

Early Results May Predict Weight Loss Success in Obesity With T2DM

September 16, 2022

Demographic and clinical variables do not predict successful weight loss in a clinical structured weight management program for adults with obesity and T2D.

Type 2 Diabetes

Type 2 Diabetes in Parkinson Disease Associates With Neuroaxonal Damage

By

Jessica Nye, PhD

September 15, 2022

Letter authors sought to evaluate the relationship between diabetes mellitus and neurofilament light concentrations in a subgroup of participants in the MARK-PD study.

Type 2 Diabetes

Dapagliflozin Linked to Consistent Reductions in CV and Kidney Outcomes in T2D

By

Sheila Jacobs

August 23, 2022

A study was conducted to determine the efficacy and safety of dapagliflozin when taken with CV medications in patients with type 2 diabetes and HF, kidney disease, or both.